Dual Stimulation for Spinal Cord Injury
Key facts
- Who runs it
- Spaulding Rehabilitation Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 8 people enrolled
- Started
- 14 Jul 2022
- Ended
- 1 Sept 2024
- Type of study
- Interventional
- Treatments tested
- tsDCS+pDCS
- Low-level laser therapy
- Record updated
- 12 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Men and women aged 18 or older with traumatic SCI (ASIA A-B)
- The injury has less than six months of evolution
- Patients admitted to the Spaulding SCI Rehabilitation Unit at Spaulding Rehabilitation Hospital
- Respiratory and hemodynamically stable
Who cannot take part
- They have any contraindications for receiving tsDCS, such as skin wounds in the place of application
- Any known hypersensitivity to light therapy
- Compromised medical status due to uncontrolled pathologies such as cancer, heart failure, kidney or liver insufficiency, or any other condition which jeopardizes the patient's participation in the study
- Pregnancy or breastfeeding. People with childbearing capacity who are eligible to participate in the study will be tested for pregnancy by serum human chorionic gonadotropin (hCG) test
- Any substantial decrease in alertness, language reception, or attention that might interfere with understanding
- Current use of a ventilator
Where in United States
- Spaulding Rehabilitation HospitalBoston, United StatesNo longer taking part
About the trial
What the trial wants to find out
The goal of this Spinal Cord Injury (SCI) Open-Label Clinical Trial is to test the safety and feasibility of the intervention. The study aims to answer whether implementing this intervention on inpatients at a specialized rehabilitation hospital is possible. All participants will receive the intervention and be asked to report side effects and tolerability. Additionally, injury markers for safety and signal recordings to detect changes will be assessed pre- and post-intervention.
The group in the trial
- Non-invasive dual electrical neuromodulation and photobiomodulationTreatment being tested
Trans-spinal direct current stimulation (tsDCS) + peripheral direct current stimulation (pDCS) Spinal maximum value 4 milliamps (mA) Peripheral maximum value 1 mA Duration per treatment 20 minutes per session Total of 10 sessions AND Low-level laser therapy (LLLT) with 635nm red diodes and 405nm violet diode
Treatment: tsDCS+pDCS and Low-level laser therapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 12 March 2026